Silodosin
23 NDCs across 8 manufacturers|21 Generic,2 Brand
Silodosin is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product was first FDA-approved on Oct 8, 2008, and the first generic was approved Mar 31, 2017. FDA's Orange Book lists 20 AB-rated (therapeutically equivalent) products for this ingredient. In 2024, Medicare Part D spent $27 million on Silodosin across 304,000 claims for 86,000 beneficiaries.
Silodosin is available as 23 NDCs from 8 manufacturers (21 generic, 2 brand), with NADAC prices from $0.27 to $8.45 per EA — the most expensive product costs about 31× the cheapest. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
23
21G / 2B
Manufacturers
8
competing in market
Price Spread
$0.27 – $8.45
per EA
7d Activity
avg +1.8% WoW · of 23 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Manufacturer Breakdown
8 manufacturers producing SILODOSIN(1 pricing outlier)
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RAPAFLO 4 MG CAPSULE | $8.4459 per EA | — |
RAPAFLO 8 MG CAPSULE | $8.3953 per EA | — |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 8 MG CAPSULE | $0.3137 per EA | +1.80% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
SILODOSIN 4 MG CAPSULE | $0.2703 per EA | +1.69% |
Frequently Asked Questions
What is Silodosin used to treat?
Silodosin is used to treat prostatic hyperplasia, per the National Library of Medicine's MED-RT classification.
When did Silodosin become available as a generic?
FDA approved the first generic Silodosin (ANDA) on Mar 31, 2017. The Orange Book currently lists 20 AB-rated products for this ingredient, meaning FDA considers them therapeutically equivalent to the brand.
How much does Medicare spend on Silodosin?
In 2024, Medicare Part D spent $27 million on Silodosin across 304,000 claims for 86,000 beneficiaries.
How many Silodosin products are on the market?
The Silodosin drug market contains 23 NDCs from 8 manufacturers — 21 generic and 2 brand products.
What is the price range for Silodosin?
NADAC reference prices for Silodosin range from $0.2703 to $8.4459 per EA — the most expensive product costs about 31× the cheapest.
Is generic Silodosin cheaper than brand?
The average generic NADAC for Silodosin is $0.2993 per EA, versus $8.4206 for brand-labeled products — brand versions average about 28× the generic price.
Which manufacturers make Silodosin?
8 manufacturers list Silodosin in NADAC. Ranked by number of NDCs, the largest are Ajanta Pharma USA Inc. (3), Camber Pharmaceuticals Inc. (3), Macleods Pharmaceuticals Limited (3), Aurobindo Pharma Limited (3), Lupin Pharmaceuticals Inc. (3).
How has the price of Silodosin changed recently?
Over the past 7 days, 21 Silodosin NDCs rose and 0 fell, with a market-wide average change of +1.8%.